Original Research

Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors

Yao JC, Chan JA, Mita AC, Kundu MG, Hermosillo Reséndiz K, Hu K, Ravichandran S, Strosberg JR, Wolin EM

OncoTargets and Therapy 2017, 10:3177-3186

Published Date: 27 June 2017